| Optoacoustic Detection of Inflammation Using MSOT Device (NCT05333978) | University of Oklahoma | 2022-05-31 |
| ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment (NCT05414552) | University of Freiburg | 2021-06-01 |
| Efficacy of a Low Fiber Diet for Pediatric Colonoscopy Prep (NCT05918562) | Rhode Island Hospital | 2021-04-20 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (NCT03819296) | M.D. Anderson Cancer Center | 2021-02-21 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients (NCT04038619) | M.D. Anderson Cancer Center | 2021-02-01 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma (NCT04407247) | M.D. Anderson Cancer Center | 2020-07-09 |
| MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. (NCT04272307) | University Hospital, Bordeaux | 2020-05-14 |
| FIT and Fecal Calprotectin in Patients With Chronic Lower GI Symptoms (NCT05514561) | Mahidol University | 2020-03-22 |
| Syndecan 1 as Biomarker for Inflammation (NCT02333526) | Helios Albert-Schweitzer-Klinik Northeim | 2019-12-01 |
| Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms (NCT03601611) | Herlev Hospital | 2019-01-01 |
| PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial (NCT03378167) | McMaster Children's Hospital | 2018-12-01 |
| Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis (NCT03014284) | The University of Texas Health Science Center at San Antonio | 2017-01-20 |
| Determination of the Aetiologies of Acute Colitis and Early Identification of Patients Requiring Diagnostic Colonoscopy (NCT02709213) | University Hospital, Geneva | 2016-11-01 |
| Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis (NCT02647866) | Kyowa Kirin, Inc. | 2016-06-01 |
| Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis (NCT02687724) | University College Dublin | 2016-06-01 |
| Intestinal Microbiome and Chronic Inflammatory Bowel Disease (NCT02768038) | Turku University Hospital | 2016-05-01 |
| Patient Centered Algorithms to Optimize the Inpatient Experience and Treatment of Ulcerative Colitis (NCT02569333) | Mount Sinai Hospital, Canada | 2016-01-01 |
| Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort (NCT02503514) | University of North Carolina, Chapel Hill | 2015-08-01 |
| The Risk for Clostridium Difficile Colitis During Hospitalization in Asymptomatic Carriers (NCT02063282) | Amos Yinnon | 2014-02-01 |
| Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. (NCT02600143) | University Medical Center Groningen | 2013-08-01 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) (NCT01369355) | Janssen Research & Development, LLC | 2011-09-13 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) (NCT01369342) | Janssen Research & Development, LLC | 2011-07-01 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) (NCT01369329) | Janssen Research & Development, LLC | 2011-07-01 |
| Intracolonic Vancomycin Therapy in Severe C. Diff Colitis (NCT01346059) | Corewell Health East | 2011-04-01 |
| NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease (NCT00936585) | National Institutes of Health Clinical Center (CC) | 2009-07-01 |
| Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (NCT00533078) | Insel Gruppe AG, University Hospital Bern | 2007-11-01 |
| Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome (NCT00514982) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-07 |
| Evaluation of DHA for the Treatment of PSC (NCT00325013) | Beth Israel Deaconess Medical Center | 2005-12-01 |
| Study to Identify Non-Invasive Markers of Gastrointestinal Allergy (NCT00272818) | Boston Children's Hospital | 2004-09-01 |
| Colonoscope Passive Bending Function (NCT00518349) | Norwegian Department of Health and Social Affairs | 2003-08-01 |
| A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease (NCT00072943) | Facet Biotech | 2002-03-01 |
| Treatment of Microscopic Colitis (NCT00184171) | Norwegian University of Science and Technology | 2001-11-01 |
| A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS (NCT00002273) | Hoffmann-La Roche | |
| A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients (NCT00000768) | National Institute of Allergy and Infectious Diseases (NIAID) | |